Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer
CD155<sup>high</sup> is a predictor of worse outcomes in patients with advanced NSCLC, predominantly among those without oncogenic alterations. CD155 could be a potential biomarker and a molecular target in patients with poor responses to current therapies.
Authors
- Hernandez-Pedro Y. Norma
- Óscar Arrieta (ORCID: https://orcid.org/0000-0002-1164-3779)
- Mario Orozco‐Morales
- L.A. San José
- Pedro Barrios‐Bernal (ORCID: https://orcid.org/0000-0002-5681-5204)
- Popa-Navarro Xitlally
- Caballé-Pérez Enrique
- Hernandez-Martinez Juan-Manuel
- Castillo-Ruiz Cesar
- Avilés-Salas Alejandro
Institutions
- Instituto Nacional de Cancerología (MX)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1186/s12967-024-05471-6
- Citations
- 3
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.72